Navigation Links
PixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (220 volts) from Arcturus, now part of Molecular Devices

ProductsPixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (220 volts) from Arcturus, now part of Molecular Devices
Company Arcturus, now part of Molecular Devices
Item PixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (220 volts)
Price 
Description Obtain Clean and Accurate Results

Laser Capture Microdissection (LCM) enables you to dramatically increase the sensitivity and accuracy of molecular assays by starting with samples of homogeneous cell types and multi-cellular structures isolated from whole tissue or cytology samples. This unique approach to microdissection-developed in 1996 at the National Institutes of Health and available exclusively from Arcturus-ensures that biological molecules such as RNA and DNA, remain undamaged during the microdissection process. Downstream molecular analysis of these molecules produces accurate and assured results that have led to over 300 peer-reviewed publications by independent researchers.

Use with All Fixed Tissue and Cell Preparations

LCM has enormous flexibility with respect to tissue and cell fixation preparations. LCM effectively extracts cells from both paraffin-embedded and frozen tissue sections prepared using a wide variety of different dyes, slide surfaces, and protocols.

Isolate Cells of Interest Quickly and Conveniently

LCM utilizes a low-power infrared laser to melt a special thermoplastic film over the cell(s) of interest. Especially developed CapSure HS or CapSure Macro Caps that are coated with this thermoplastic film are placed on the tissue section or cytology sample. The PixCell IIe LCM instrument is then used to direct the laser through the cap to melt the film onto the cells of interest. When you lift the cap, the selected cells remain attached and are captured for further analysis.

Info Arcturus, now part of Molecular DevicesArcturus, now part of Molecular Devices
400 Logue Avenue
Mountain View, CA 94043, USA
Customer Service: 650.962.3020
Fax Number: 650.962.3039
Web Site: http://www.arctur.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. PixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (110 volts) from Arcturus, now part of Molecular Devices
2. Full-Configuration Camera Link NI PCIe-1429 from National Instruments Corporation
3. Bio-Stack Twister II Microplate Handler from BioTek Instruments
4. ELx50 Microplate Strip Washer from BioTek Instruments
5. Bio-Stack Microplate Stacker from BioTek Instruments
6. DMWB3-223ASC Digital Compound DIN from Motic Instruments, Inc.
7. DMWB1-223ASC Digital Compoud DIN from Motic Instruments, Inc.
8. Precision XS Microplate Sample Processor from BioTek Instruments
9. Synergy HT Multi-Detection Microplate Reader from BioTek Instruments
10. RapidCycler 2 Instrument from Idaho Technology Inc.
11. DMW-143 FBGG Digital Stereo Zoom from Motic Instruments, Inc.
Rat Epidermal Keratinocytes (REK) (>500,000 cells)...
anti-Yan 8B12H9...
sPLA2-XII Human, Rabbit Polyconal Antibody Anti-Human sPLA2-XII Antibody was raised in rabbits against Human sPLA2-XII His-Tagged Fusion Protein Antigen: The recombinant human protein sPLA-XII...
... Expand the computing power of your ValveBank system! ... with a PC computer running Windows 98, 2000, ... unlimited programs to disk, print out program listings, ... in one simple step., EasyCode is used for ...
Biology Products:
(Date:7/7/2015)... June 30, 2015 ... the addition of the "Capacitive Fingerprint Sensors ... To this date, fingerprint sensing technology is ... fingerprint sensors are well developed. This patent landscape ... The domain of capacitive fingerprint sensors ...
(Date:7/2/2015)... June 25, 2015 ... addition of the "Natural Language Processing Market ... IVR, OCR, Pattern & Image Recognition) - Worldwide ... The key vendors occupying the market ... Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute Inc., ...
(Date:6/30/2015)... , June 30, 2015 To bolster its ... provider HYPR Corp. announced today the addition of two new ... serve as board advisor and David Raviv will ... team underscore HYPR Corp.,s commitment to providing the most secure ... Dimitri Sirota co-founded Layer 7 Technologies, a provider of ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... team has found a way to stabilize hemoglobin, the ... could lead to the development of stable vaccines and ... involves wrapping the polymer poly(acrylic acid) around hemoglobin, protecting ... allowing it to maintain its biological function and structural ...
... development along the edges of most public forests in Oregon ... study conducted by the U.S. Forest Service Pacific,s Northwest (PNW) ... photography to inventory structures at the fringes of public forests, ... two states before and after the enactment of land use ...
... and Cellular Plasticity symposium will focus on how epigenetic ... lead to cellular plasticity. WHEN/WHERE: Thursday ... Center of the National Academies of Sciences and Engineering ... to attend should contact Catherine Cao at cepmet@uci.edu ...
Cached Biology News:New method for stabilizing hemoglobin could lead to stable vaccines, artificial blood 2New method for stabilizing hemoglobin could lead to stable vaccines, artificial blood 3Development near Oregon, Washington public forests 2Top scientists to present at Epigenetic Control and Cellular Plasticity symposium 2
(Date:7/30/2015)... , July 30, 2015 According ... Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity ... Development, Preclinical, Clinical Trial), by End Users - Global ... is expected to reach USD 2,107.99 million by 2020 ... of 15.29%. Browse more than ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
(Date:7/29/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) today ... Financial Officer has resigned.  The Company has hired ... retired in December 2014, as full time interim CFO ... Andy Ashworth began his employment ... smooth transition.  Andy was the Company,s CFO from September ...
Breaking Biology Technology:Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3